ArticleEndocrine, metabolic & immune disorders drug targets2026
Assessment of Sonographic Ovarian Volume as an Potential Predictor of Polycystic Ovarian Syndrome (PCOS): A Hospital-Based Cross-Sectional Study
Article in Endocrine, metabolic & immune disorders drug targets, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionPolycystic ovarian syndrome (PCOS) is a prevalent endocrine and metabolic disorder commonly associated with obesity and reproductive morbidities. The relationship between ovarian volume and BMI as well as ovarian morphology was therefore examined in this study to assess whether sonographic ovarian volume can serve as a supportive parameter in predicting PCOS in clinical practice.
methodsA hospital-based cross-sectional study of 100 women aged 20–40 years was conducted at the University of Lahore Teaching Hospital from December 2023 to September 2024. Participants were stratified according to normal weight (BMI < 25 kg/m2) and elevated BMI (BMI ≥ 25 kg/m2) groups with healthy and PCOS as subgroups within each group.
resultsThe left ovarian volume in PCOS patients was significantly larger than that in women without PCOS (mean 13.5 mL (SD 3.6) vs 10.4 mL (SD 1.9), P < 0.05). Likewise, the mean follicle size in the left ovary was also significantly larger in women with PCOS than in normal controls, 6.3 mm (SD 1.7) and 5.6 mm (SD 1.1), respectively (P < 0.05). PCOS showed a significant association with amenorrhea (85%) and acne (66%); however, 59% of participants showed hirsutism which was not significant. DISCUSSION: The observed asymmetry in ovarian volume and the influence of BMI suggest underlying physiological variability. However, the absence of hormonal and metabolic data limits the interpretation, warranting cautious application of these findings.
conclusionOvarian volume alone is not a reliable diagnostic marker for PCOS. While the left ovary showed significant differences, the inconsistent findings support the need for a combined clinical, biochemical, and sonographic approach.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.